Inhibition of S1R led to transcriptional modifications of myofibril-associated genes, aberrant changes in the cytoskeleton and decreased beating frequency, despite reducing infection and viral replication of SARS-CoV-2 and preventing viral-associated cytokine release and cell death. This evidence concerns the gene TMBIM4 and infection.